Optimi Health Corp., headquartered in Vancouver, Canada, is a leading drug manufacturer specializing in the production and formulation of psychedelic substances for mental health treatments. Licensed by Health Canada, Optimi focuses on producing GMP-certified MDMA and natural psilocybin to address conditions such as depression and PTSD. The company operates two state-of-the-art facilities totaling 20,000 square feet in Princeton, British Columbia, ensuring cost-effective, high-quality production. Committed to advancing mental health care, Optimi Health is positioned to supply these substances to regulated markets worldwide, contributing to innovative therapeutic solutions.